Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine.

Autor: Thunold S; Dept of Oncology, Oslo University Hospital, Oslo, Norway. solthu@ous-hf.no.; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. solthu@ous-hf.no., Hernes E; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Farooqi S; Dept of Oncology, Oslo University Hospital, Oslo, Norway.; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Öjlert ÅK; Dept of Oncology, Oslo University Hospital, Oslo, Norway.; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Francis RJ; Dept of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Australia.; Medical School of The University of Western Australia, Perth, Australia., Nowak AK; Medical School of The University of Western Australia, Perth, Australia.; National Centre for Asbestos-Related Diseases, University of Western Australia, Perth, Australia.; Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia., Szejniuk WM; Clinical Cancer Research Center & Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Nielsen SS; Department of Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark., Cedres S; Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Perdigo MS; Dept of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Sørensen JB; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Meltzer C; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Mikalsen LTG; Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.; Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway., Helland Å; Dept of Oncology, Oslo University Hospital, Oslo, Norway.; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Malinen E; Dept of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Physics, University of Oslo, Oslo, Norway., Haakensen VD; Dept of Oncology, Oslo University Hospital, Oslo, Norway.; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Aug 12. Date of Electronic Publication: 2024 Aug 12.